Orbion Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ORBION PHARMS, and what generic and branded alternatives to ORBION PHARMS drugs are available?
ORBION PHARMS has twenty-nine approved drugs.
Drugs and US Patents for Orbion Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Orbion Pharms | MEMANTINE HYDROCHLORIDE | memantine hydrochloride | TABLET;ORAL | 090044-002 | Mar 12, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Orbion Pharms | VENLAFAXINE HYDROCHLORIDE | venlafaxine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 091123-002 | Jul 11, 2011 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Orbion Pharms | CETIRIZINE HYDROCHLORIDE ALLERGY | cetirizine hydrochloride | TABLET;ORAL | 078862-001 | Feb 19, 2009 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Orbion Pharms | SUMATRIPTAN SUCCINATE | sumatriptan succinate | TABLET;ORAL | 078284-002 | Aug 10, 2009 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Orbion Pharms | ARIPIPRAZOLE | aripiprazole | TABLET;ORAL | 202683-006 | May 23, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Orbion Pharms | OLANZAPINE | olanzapine | TABLET;ORAL | 202287-004 | Apr 23, 2012 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.